Ophthalmologica.:全氟正辛烷的单层倒置内限膜瓣技术对较大的黄斑裂孔具有良好的治疗效果!

2017-07-20 cuiguizhong MedSci原创

韩国釜山仁济大学海云台拜科医院眼科系的Lee JE教授团队近日在Ophthalmologica.发表了他们的一项重要工作,他们评估了全氟正辛烷的单层倒置内限膜瓣(ILM)对较大的黄斑裂孔(MH)的疗效。

韩国釜山仁济大学海云台拜科医院眼科系的Lee JE教授团队近日在Ophthalmologica.发表了他们的一项重要工作,他们评估了全氟正辛烷的单层倒置内限膜瓣(ILM)对较大的黄斑裂孔(MH)的疗效。

他们对先天性黄斑裂孔MH> 400μm的患者进行了回顾性研究。患者分为ILM剥离组(P组,51例眼)和ILM瓣组(F组,41例眼)。他们将黄斑裂孔MH闭合程度,最佳矫正视力(BCVA)和术后光学相干断层扫描结果来作为分析结果。

他们发现,黄斑裂孔在P组88.2%闭合,在F组100%闭合(p = 0.032)。 P组和F组分别用SF6和空气作为填充。两组在最佳矫正视力(BCVA)方面有显着改善。 3个月内 F组比P组效果更好,但到6个月时两者无显着差异。 6个月时,恢复椭圆形区和外界膜都得到恢复,但两者没有显着性差异。

因此,他们认为,因为填充气体会妨碍早期康复,因此在不使用长效气体的情况下,单层倒置ILM瓣对于较大的黄斑裂孔(MH)的闭合比ILM剥离更好。这项工作为较大的黄斑裂孔治疗提供了新的方法。

原文出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1893972, encodeId=018618939e25d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64637, encryptionId=5e456463eee, topicName=治疗效果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu Jan 18 09:03:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755042, encodeId=376d1e550427c, content=<a href='/topic/show?id=a2f510314e7d' target=_blank style='color:#2F92EE;'>#黄斑裂孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103147, encryptionId=a2f510314e7d, topicName=黄斑裂孔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb9536829285, createdName=360611852, createdTime=Wed May 23 22:03:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525095, encodeId=63961525095ef, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103133, encryptionId=65e91031337f, topicName=黄斑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638b11619344, createdName=muzishouyi, createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541244, encodeId=0571154124412, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224200, encodeId=076f224200f3, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Jul 20 10:12:18 CST 2017, time=2017-07-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1893972, encodeId=018618939e25d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64637, encryptionId=5e456463eee, topicName=治疗效果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu Jan 18 09:03:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755042, encodeId=376d1e550427c, content=<a href='/topic/show?id=a2f510314e7d' target=_blank style='color:#2F92EE;'>#黄斑裂孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103147, encryptionId=a2f510314e7d, topicName=黄斑裂孔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb9536829285, createdName=360611852, createdTime=Wed May 23 22:03:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525095, encodeId=63961525095ef, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103133, encryptionId=65e91031337f, topicName=黄斑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638b11619344, createdName=muzishouyi, createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541244, encodeId=0571154124412, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224200, encodeId=076f224200f3, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Jul 20 10:12:18 CST 2017, time=2017-07-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1893972, encodeId=018618939e25d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64637, encryptionId=5e456463eee, topicName=治疗效果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu Jan 18 09:03:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755042, encodeId=376d1e550427c, content=<a href='/topic/show?id=a2f510314e7d' target=_blank style='color:#2F92EE;'>#黄斑裂孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103147, encryptionId=a2f510314e7d, topicName=黄斑裂孔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb9536829285, createdName=360611852, createdTime=Wed May 23 22:03:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525095, encodeId=63961525095ef, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103133, encryptionId=65e91031337f, topicName=黄斑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638b11619344, createdName=muzishouyi, createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541244, encodeId=0571154124412, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224200, encodeId=076f224200f3, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Jul 20 10:12:18 CST 2017, time=2017-07-20, status=1, ipAttribution=)]
    2017-07-22 muzishouyi
  4. [GetPortalCommentsPageByObjectIdResponse(id=1893972, encodeId=018618939e25d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64637, encryptionId=5e456463eee, topicName=治疗效果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu Jan 18 09:03:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755042, encodeId=376d1e550427c, content=<a href='/topic/show?id=a2f510314e7d' target=_blank style='color:#2F92EE;'>#黄斑裂孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103147, encryptionId=a2f510314e7d, topicName=黄斑裂孔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb9536829285, createdName=360611852, createdTime=Wed May 23 22:03:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525095, encodeId=63961525095ef, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103133, encryptionId=65e91031337f, topicName=黄斑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638b11619344, createdName=muzishouyi, createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541244, encodeId=0571154124412, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224200, encodeId=076f224200f3, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Jul 20 10:12:18 CST 2017, time=2017-07-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1893972, encodeId=018618939e25d, content=<a href='/topic/show?id=5e456463eee' target=_blank style='color:#2F92EE;'>#治疗效果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64637, encryptionId=5e456463eee, topicName=治疗效果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Thu Jan 18 09:03:00 CST 2018, time=2018-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755042, encodeId=376d1e550427c, content=<a href='/topic/show?id=a2f510314e7d' target=_blank style='color:#2F92EE;'>#黄斑裂孔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103147, encryptionId=a2f510314e7d, topicName=黄斑裂孔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb9536829285, createdName=360611852, createdTime=Wed May 23 22:03:00 CST 2018, time=2018-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525095, encodeId=63961525095ef, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103133, encryptionId=65e91031337f, topicName=黄斑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=638b11619344, createdName=muzishouyi, createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541244, encodeId=0571154124412, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sat Jul 22 00:03:00 CST 2017, time=2017-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=224200, encodeId=076f224200f3, content=继续学习。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Thu Jul 20 10:12:18 CST 2017, time=2017-07-20, status=1, ipAttribution=)]
    2017-07-20 doctorJiangchao

    继续学习。

    0

相关资讯

Ophthal Plast Reconstr Surg: 下眼睑的椭圆平滑肌肿瘤:探索其可能的原因!

马萨诸塞州眼耳道医院眼科病理实验室的 Bojovic B.教授近日在最新一期的Ophthal Plast Reconstr Surg杂志上发表了他们的一项探索性工作,对下眼睑的椭圆平滑肌肿瘤出现的原因进行了探索。

J Ayub Med Coll Abbottabad.:眼球创伤评分系统在战斗眼损伤中的预测!

巴基斯坦卡拉奇PNS Shifa海军医院眼科系Mehboob MA团队近日在J Ayub Med Coll Abbottabad发表了他们的一项重要工作,验证眼球创伤评分(OTS)系统在战斗过程整个眼睛损伤患者中的预测价值。

Clin Exp Ophthalmol. :眼科的临床转化和历程!

澳大利亚悉尼新南威尔士大学眼科系的Minas Coroneo AO近日在Clin Exp Ophthalmol.发表了一篇综述,从临床到基础研究和生物技术等诸多领域,对与 翼状胬肉,眼表面鳞状肿瘤,干眼综合征,角膜修复和置换,白内障手术,斜视手术和仿生眼相关的研究进行详细论述。

Am J Ophthalmol.:对中、后期和全葡萄膜炎使用不同抗代谢药物治疗的生活质量研究!

加利福尼亚大学眼科系的Acharya NR教授团队在最新的一期Am J Ophthalmol.杂志上发表了他们的一项研究工作,他们研究了用最常用的2种抗代谢药物来治疗非感染性葡萄膜炎,观察患者的生活质量变化。

Dev Dyn:泪腺发育:从信号传导互作到再生医学!

美国哥伦比亚大学眼科Zhang X教授近日在Dev Dyn发表了一篇综述,系统的介绍了泪腺的发育。从外在信号传导相互作用到控制泪腺形态发生的内在转录网络,在到治疗干眼病的再生医学领域,从多个角度探究泪腺发育的过程。

Int Ophthalmol.:急性淋巴细胞白血病的复发表现为浆液性视网膜脱落和视盘肿胀!

土耳其伊斯坦布尔的巴西希尔大学Göztepe医院眼科系的Toygar O在最新的一期Int Ophthalmol.杂志上发表了他们观察到的一个病例,该病例报告描述了一名患有急性淋巴细胞性白血病(ALL)的患者,该患者出现双侧浆液性视网膜脱落和单侧视盘肿胀的临床症状。